As of 3:59pm ET
| +0.07 / +2.99%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 3.85, with a high estimate of 4.00 and a low estimate of 3.70. The median estimate represents a +59.75% increase from the last price of 2.41.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.